Nexalin Technology (NXL) Change in Accured Expenses (2022 - 2026)

Nexalin Technology has reported Change in Accured Expenses for 5 years, with the latest figure at $218239.0 in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 754.63% year-over-year to $218239.0 in Q2 2026; TTM through Jun 2026 was $498500.0, a 112.09% increase from a year earlier, with the FY2025 full-year figure at $252009.0, up 94.66% from the prior year.
• Change in Accured Expenses was $218239.0 for Q2 2026 at Nexalin Technology, up from -$2489.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $318723.0 in Q4 2025, with the low at -$230747.0 in Q2 2024.
• Average Change in Accured Expenses over 5 years is $29599.4, with a median of $6927.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses tumbled 3963.17% in 2024, then surged 754.63% in 2026.
• Over 5 years, Change in Accured Expenses stood at $97322.0 in 2022, then slumped by 336.95% to -$230607.0 in 2023, then surged by 211.83% to $257898.0 in 2024, then advanced by 23.58% to $318723.0 in 2025, then slumped by 31.53% to $218239.0 in 2026.
• The last three Change in Accured Expenses figures came in at $218239.0 (Q2 2026), -$2489.0 (Q1 2026), and $318723.0 (Q4 2025), per Business Quant data.